MedPath

WAVE Study- Walking and Aging in VErona Study

Not Applicable
Conditions
Sarcopenic Obesity
Cardiovascular Risk Factor
Metabolic Syndrome
Hypertension
Disability Physical
Overweight and Obesity
Abdominal Obesity
Interventions
Behavioral: Diet
Behavioral: Walking
Behavioral: Nordic Walking
Registration Number
NCT03212391
Lead Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Brief Summary

Monocentric unblinded two parallel-group randomized controlled trial to evaluate the effect of diet with or without Nordic Walking on weight loss, physical performance and cardiovascular risk factors in overweight and obese population

Detailed Description

To examine the impact of a 48-week of diet +/- Nordic Walking program on physical performance, muscle function, cardiovascular risk factors and arterial stiffness in community-dwelling overweight and obese elderly men and women.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • 60-90 years

    • Males and females

      . BMI > 27 kg/m2

    • living in Verona (Italy)

    • stable weight in the 3 months

    • not involved in physical exercise programs

    • informed consent sign

Exclusion Criteria
  • cardiovascular disease (unstable angina, recent myocardial infarction, cardiac arrhythmias, heart failure, valvular heart disease, aortic aneurysm, recent intracerebral or subdural hemorrhage, not controlled hypertension)
  • musculoskeletal disease (symptomatic discal hernia, symptomatic arthrosis, acute articular, tendon or ligament lesions, hip prothesis).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diet+WalkingDiet52 weeks of Diet+26 weeks supervised Walking 3 times per week, followed by 26 weeks of unsupervised Walking
Diet+WalkingWalking52 weeks of Diet+26 weeks supervised Walking 3 times per week, followed by 26 weeks of unsupervised Walking
Diet+Nordic WalkingNordic Walking52 weeks of Diet+26 weeks supervised Nordic Walking 3 times per week, followed by 26 weeks of unsupervised Nordic Walking
Diet+Nordic WalkingDiet52 weeks of Diet+26 weeks supervised Nordic Walking 3 times per week, followed by 26 weeks of unsupervised Nordic Walking
Primary Outcome Measures
NameTimeMethod
VO2 max12 months

maximal oxygen consumption

Secondary Outcome Measures
NameTimeMethod
PWV3, 6, 9 and 12 months

pulse wave velocity

VO2 max changes3, 6, 9 and 12 months

maximal oxygen consumption

muscle mass3, 6, 9 and 12 months
SF 366 and 12 months

quality of life

muscle strength3, 6, 9 and 12 months
fat mass3, 6, 9 and 12 months
GDS6 and 12 months

geriatric depression scale

Trial Locations

Locations (1)

AOUI Verona

🇮🇹

Verona, Italy

© Copyright 2025. All Rights Reserved by MedPath